Top Markets
Coin of the day
Chengdu Easton Biopharmaceuticals Co., Ltd. Chengdu Easton Biopharmaceuticals Co., Ltd.

Chengdu Easton Biopharmaceuticals Co., Ltd.

688513
Classifica tra le azioni #9010
Chengdu Easton Biopharmaceuticals Co., Ltd. is a pharmaceutical enterprise... Chengdu Easton Biopharmaceuticals Co., Ltd. is a pharmaceutical enterprise dedicated to the full spectrum of drug development, encompassing research, development, production, and market distribution of medicinal products. The company offers finished medications tailored for various medical disciplines, including pain management (anesthetics/analgesics), cardiovascular health, oncology, and pediatrics. Beyond ready-to-use drugs, it also manufactures active pharmaceutical ingredients (APIs) for a broader range of therapeutic areas, such as cancer treatment, heart conditions, pain relief, anti-inflammatory uses, gastrointestinal issues, antiemetics, neurological and psychiatric disorders, and urinary system ailments. Established in 2009, the firm is headquartered in Chengdu, China.
Prezzo delle azioni
$6.32
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$1.11B
Variazione (1 giorno)
-1.63%
Variazione (1 anno)
-31.28%
Paese
CN
Scambia Chengdu Easton Biopharmaceuticals Co., Ltd. (688513)

Categoria

Storico del rendimento da dividendi per Chengdu Easton Biopharmaceuticals Co., Ltd. (688513)
Il rendimento da dividendi (TTM) di Chengdu Easton Biopharmaceuticals Co., Ltd. (simbolo azionario: 688513) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Chengdu Easton Biopharmaceuticals Co., Ltd. (688513) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
0.00%
US
0.00%
NL
3.12%
AU
0.00%
US
0.00%
CH